(Reuters) -Medtech firm Heartflow was valued at $2.27 billion on Friday, with its shares surging 47.4% in the Nasdaq debut, ...

Bain Capital Specialty Finance delivered a strong Q2, reinforcing its value, dividend safety, and limited downside risk. Read ...

Heartflow (NASDAQ: HTFL) stock surges ~50% as the company focused on AI-driven tools for the diagnosis of heart diseases make ...

Heartflow, backed by private investment firm Bain Capital, said on Wednesday it was targeting a valuation of up to $1.46 ...

Bain Capital Specialty Finance Inc (NYSE:BCSF) is set to release its Q2 2025 earnings on Aug 6, 2025. The consensus estimate ...

On a per-share basis, the Boston-based company said it had profit of 37 cents. Earnings, adjusted for investment costs, were ...

Heartflow is advancing coronary care by transforming coronary artery disease into a screenable, diagnosable, and manageable ...

Pharma is looking for fewer, scaled providers at an enterprise level to reduce risk and provide a better-integrated service,' ...

Bain Capital and 11North Partners paid $395 million for a portfolio of 10 shopping centers in Florida and South Carolina, ...

Bristol Myers Squibb (BMS) and Bain Capital have created an independent biopharmaceutical company to develop immunology ...

Japanese aircraft interiors manufacturer Jamco Corporation is seeking to cash in on a global shortage of new plane seats by reentering the business class seat market under its new owner, Bain Capital, ...

Heartflow, Inc. (NASDAQ:HTFL) successfully raised $316.7 million from its IPO, having sold 16.67 million shares at a price of ...